The combination of anti-PD-1 therapy and enhanced FA catabolism works together to significantly decrease the size of melanoma tumors in mice while fostering the antitumor metabolic reprogramming of CD8 + T cells [75]. This evidence concerns the gene CD8A and melanoma.